News

Trump Administration Releases New COVID-19 Vaccine Plan: What to Know
In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
FDA to limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...
Layoffs come to Ventura County schools as COVID-19 grants end, enrollment shrinks
Ventura Unified, Oxnard Union and the Ventura County Office of Education each approved dozens of final layoff notices, though ...
Trump administration ends approval of annual COVID-19 shots for many
A vaccine expert at Children’s Hospital of Philadelphia warns: “The only thing that can come of this will make vaccines less ...
Explore more
How COVID-19 continues to impact Utah teens, 5 years later
Hill describes how there has been an increase in general distress, as well as anxiety rates, eating disorders, and body ...
MERS Coronavirus Infection Remains A Threat In The Middle East
Saudi Arabia reported nine cases and two deaths from MERS-CoV infection that occurred between March 1 and April 21, 2025.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
FDA will limit COVID-19 vaccine to those over 65 or at high risk
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over age 65 or those at risk for severe infection.